| Income Statement |
| Total Revenue | 3.92M |
|
| Revenues (USD) | 3.92M |
| Cost of Revenue | 1.39M |
| Gross Profit | 2.53M |
| Operating Expenses | 3.00M |
| Research and Development Expense | 936.00K |
| Selling, General and Administrative Expense | 1.82M |
| Operating Income | -470.00K |
| Interest Expense | -6.00K |
| Income Tax Expense | 5.00K |
| Net Income | -468.00K |
| Net Income Common Stock | -468.00K |
| Net Income Common Stock (USD) | -468.00K |
| Consolidated Income | -468.00K |
| Earnings per Basic Share | -0.04 |
| Earnings per Basic Share (USD) | -0.04 |
| Earnings per Diluted Share | -0.04 |
| Earning Before Interest & Taxes (EBIT) | -469.00K |
| Earning Before Interest & Taxes (USD) | -469.00K |
| Weighted Average Shares | 12.15M |
| Weighted Average Shares Diluted | 12.15M |
| Balance Sheet |
| Cash and Equivalents | 1.47M |
| Cash and Equivalents (USD) | 1.47M |
| Trade and Non-Trade Receivables | 1.25M |
| Current Assets | 3.25M |
| Property, Plant & Equipment Net | 864.00K |
| Total Assets | 15.33M |
| Debt Current | 288.00K |
| Total Debt | 986.00K |
| Current Liabilities | 5.33M |
| Debt Non-Current | 698.00K |
| Total Liabilities | 6.43M |
| Accumulated Retained Earnings (Deficit) | -95.04M |
| Accumulated Other Comprehensive Income | -319.00K |
| Shareholders Equity | 8.89M |
| Shareholders Equity (USD) | 8.89M |
| Assets Non-Current | 12.07M |
| Total Debt (USD) | 986.00K |
| Deferred Revenue | 2.85M |
| Goodwill and Intangible Assets | 11.11M |
| Liabilities Non-Current | 1.11M |
| Trade and Non-Trade Payables | 1.23M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 179.00K |
| Net Cash Flow from Financing | -23.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | 92.00K |
| Capital Expenditure | -43.00K |
| Issuance (Repayment) of Debt Securities | -21.00K |
| Net Cash Flow from Investing | -43.00K |
| Net Cash Flow from Operations | 155.00K |
| Effect of Exchange Rate Changes on Cash | 3.00K |
| Share Based Compensation | 120.00K |